Letter: tacrolimus may be hazardous in decompensated autoimmune liver disease with hyperbilirubinemia-authors' reply
Aliment Pharmacol Ther
.
2018 Jun;47(11):1568-1569.
doi: 10.1111/apt.14651.
Authors
Y S de Boer
1
,
R Liberal
2
,
M A Heneghan
2
Affiliations
1
Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
2
Institute of Liver Studies, King's College Hospital, London, UK.
PMID:
29878432
DOI:
10.1111/apt.14651
No abstract available
Publication types
Letter
Comment
MeSH terms
Hepatitis, Autoimmune*
Humans
Hyperbilirubinemia
Immunosuppressive Agents
Liver Diseases*
Tacrolimus
Substances
Immunosuppressive Agents
Tacrolimus